pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
pharmadog news

Browse

292 stories matching this filter · ← front page

★ save view↓export CSV
rangeto
sort
recentoldestsourcealpha
source
STAT792Endpoints594BioPharma Dive228onclive165BioSpace64Fierce Biotech64raps29
therapy area
allOncology81Cardiology27Psychiatry & CNS21Vaccines17Immunology17Rare Disease12Hepatology6
  • Biogen pushing tau drug forward despite Alzheimer’s study failure
    <figure><div><img src="https://imgproxy.divecdn.com/Uto2VRn61o7u_sFbw6zPAlwZMdRxZOBYNj0bVh4-oRI/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9CaW9nZW5fUGhvdG9fMy5KUEc=.webp"/><…
    BioPharma Dive · 2mo ago↗ source
  • With new data, Regenxbio to seek FDA approval of Duchenne gene therapy
    <figure><div><img src="https://imgproxy.divecdn.com/URuUijrNJW-L44_y5Wz5m0hLgGi4R29BBYR8egTUghQ/g:nowe:327:163/c:3508:1982/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWd…
    BioPharma Dive · 2mo ago↗ source
  • FDA’s leadership void leaves biotech with renewed ‘uncertainty’
    <figure><div><img src="https://imgproxy.divecdn.com/FNb_NTnh8G1qxJJ4-eXNdCf1X5Oo0JaGYzOyuwyRsW4/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0yMjEzNTk5ODA2XzEua…
← prev
page 10 of 12
next →
Hematology6
Pulmonology5
Infectious Disease4
Ophthalmology3
Dermatology2
BioPharma Dive · 2mo ago
↗ source
  • Lilly data point to ‘maintenance’ strategies for GLP-1 weight loss
    <figure><div><img src="https://imgproxy.divecdn.com/8nTrHlsFTcngJswJxr_8afos9dxh_YxQE6LZmgMA2_I/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0yMDkyNDczMjEzX2VHa…
    BioPharma Dive · 2mo ago↗ source
  • Assertio accepts new buyout bid; AI biotech Isomorphic banks $2B
    <figure><div><img src="https://imgproxy.divecdn.com/idsdMAHsPbXObDUtQW2qRG7uveBUVv6HCTn9NTtlDOI/g:nowe:0:0/c:1207:682/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0x…
    BioPharma Dive · 2mo ago↗ source
  • [Podcast] Closing the Distance in Cancer Care
    <figure><div><img src="https://imgproxy.divecdn.com/dY7Wm0PCubv9b4fcIzKfj5an0kT_H96KaWu7liYNw1Y/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9NY0tlc3Nvbl9Qb2RjYXN0XzEzNDZ4NzI5X…
    BioPharma Dive · 2mo ago↗ source
  • FDA chief Marty Makary resigns from agency, ending tumultuous tenure
    <figure><div><img src="https://imgproxy.divecdn.com/lfiTfXKtJER0ScsazbccJFY15dK3uUIVJZ6JBQZD8TA/g:nowe:0:104/c:1024:578/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy…
    BioPharma Dive · 2mo ago↗ source
  • Arvinas, Pfizer find new partner for ‘Protac’ breast cancer drug
    <figure><div><img src="https://imgproxy.divecdn.com/xFVDAUb89QQFVPrJL8faaWdXxcY16WqAOJqd9TV5Hi0/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMzY5MDAzNjAwLmpwZ…
    BioPharma Dive · 2mo ago↗ source
  • Bristol Myers, Hengrui join forces in drugmaking alliance worth up to $15.2 billion
    <figure><div><img src="https://imgproxy.divecdn.com/d3kyAOKiV4alroZs496u4_W_RA0u2QbwRQbzfwY4ALY/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xNjg5NTg1NDg3X3JmN…
    BioPharma Dive · 2mo ago↗ source
  • A year after Vertex’s big launch, pain drug research faces a pivotal moment
    <p>Journavx revived an area of development long considered a graveyard. Can any other pain drugs keep investor excitement going?</p>
    BioPharma Dive · 2mo ago↗ source
  • GSK cuts deal with Sino to broaden reach of hepatitis B drug
    <figure><div><img src="https://imgproxy.divecdn.com/mDk-h3NLB8udDPFuDlI7IPou1i9tJKJYucQXUnhK9vA/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0yMTc3MzEzMjc4LmpwZ…
    BioPharma Dive · 2mo ago↗ source
  • Inhibrx delivers ‘differentiated’ cancer drug data; Fractyl starts diabetes gene therapy trial
    <figure><div><img src="https://imgproxy.divecdn.com/idsdMAHsPbXObDUtQW2qRG7uveBUVv6HCTn9NTtlDOI/g:nowe:0:0/c:1207:682/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0x…
    BioPharma Dive · 2mo ago↗ source
  • Biotech layoffs are easing, but is the worst over?
    <figure><div><img src="https://imgproxy.divecdn.com/TL3Qf7mHRlVjEhCJI35ocLIfavZ0TUEHiNIVNf4xjm8/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9TY3JlZW5zaG90XzIwMjYtMDUtMDdfYXRfM…
    BioPharma Dive · 2mo ago↗ source
  • Precision in motion: Decoding the critical operations behind the logistics of next-generation cell and gene therapies
    <p>The future of medicine is here. See how specialized logistics are saving lives with next-gen cell and gene therapies.</p>
    BioPharma Dive · 2mo ago↗ source
  • The capacity crunch in biopharma is a location problem
    <p>Cell and gene therapies aren’t limited by ideas—they’re limited by where they’re built. See how “ready-now” locations change the math on scaling.</p>
    BioPharma Dive · 2mo ago↗ source
  • Lilly to invest extra $4.5B across Indiana manufacturing
    <figure><div><img src="https://imgproxy.divecdn.com/8nTrHlsFTcngJswJxr_8afos9dxh_YxQE6LZmgMA2_I/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0yMDkyNDczMjEzX2VHa…
    BioPharma Dive · 2mo ago↗ source
  • FDA to reevaluate spurned cell therapy; Under-the-skin Leqembi review extended
    <figure><div><img src="https://imgproxy.divecdn.com/idsdMAHsPbXObDUtQW2qRG7uveBUVv6HCTn9NTtlDOI/g:nowe:0:0/c:1207:682/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0x…
    BioPharma Dive · 2mo ago↗ source
  • Lilly, Gilead lead pharma’s M&A boom
    <figure><div><img src="https://imgproxy.divecdn.com/wW2Sw-v1m2RoAnzb6Llg6MP71MxLlDb61aNlxns-F98/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMjIxODc5NzA5X2RKS…
    BioPharma Dive · 2mo ago↗ source
  • Odyssey, on second try, snags $279M in an IPO
    <figure><div><img src="https://imgproxy.divecdn.com/szYDL8kkQd6XaSVgvjJPYl2j0snveijWs_0sZ-B522Y/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xNDYyODUzODA3LmpwZ…
    BioPharma Dive · 2mo ago↗ source
  • Sarepta tumbles as its gene therapy sales decline further
    <figure><div><img src="https://imgproxy.divecdn.com/XaTqfcte0RAZt6-RIcgWQ5i2KmL-mKKasPXR8xjfQW8/g:nowe:0:858/c:4256:2405/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9TYXJlcHRhX0Jvc…
    BioPharma Dive · 2mo ago↗ source
  • Angelini to buy Catalyst in $4B play for rare neuro drugs
    <figure><div><img src="https://imgproxy.divecdn.com/4_eQ3BQP0sHe3AjR5s7bySznoaDhyqMpmhkmNubOdkU/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xNDQwMTY4MDMyXzEua…
    BioPharma Dive · 2mo ago↗ source
  • Entrada shares dive as Duchenne results disappoint
    <figure><div><img src="https://imgproxy.divecdn.com/xa_T0oT9Hj8F-wJjKfJeFkbn4Yqp_lT58dL0S4GszxY/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy02MjEzNjQ4MDJfMS5qc…
    BioPharma Dive · 2mo ago↗ source
  • Roche to acquire digital pathology firm PathAI in deal potentially worth over $1B
    <figure><div><img src="https://imgproxy.divecdn.com/Q9vt9_gxDkyyl1zgpo6ZBBNf6InJ95ZMxSRGRm4nTFk/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS8yQTROWEtOLmpwZw==.webp"/></div></f…
    BioPharma Dive · 2mo ago↗ source
  • Bayer to buy Perfuse for up to $2.45B, bolstering eye drug pipeline
    <figure><div><img src="https://imgproxy.divecdn.com/gRkyNZ1AbgGTL_5MqeKhbG0YuhnzTHcUYxQb5ULTKUc/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0yMjA4MzAxNTQ0LmpwZ…
    BioPharma Dive · 2mo ago↗ source
  • Novo hikes guidance on Wegovy pill’s fast sales start
    <p>In its latest earnings report, the Danish drugmaker said sales and profit should shrink less than the company originally anticipated thanks to strong prescription numbers for its new obesity pil…
    BioPharma Dive · 2mo ago↗ source